npr

Scientists have taken a small step toward personalizing treatment for depression.

A study of more than 300 people with major depression found that brain wave patterns predicted which ones were most likely to respond to the drug sertraline (Zoloft), a team reported Monday in the journal Nature Biotechnology.

If the approach pans out, it could offer better care for the millions of people in the U.S. with major depression.